Clinical Trials Browser

Phase 2/3 × Unknown × Lenalidomide × Clear all

NCT03759093 2023-09-06

CURATE.AI Optimized Modulation for Multiple Myeloma

Phase 2/3 Unknown

Multiple Myeloma